HRA Pharma Targets ‘Life Enthusiasts’ In The UK With New Compeed Campaign
HRA Pharma targets active consumers in its new £2.5m multi-channel UK marketing campaign for recently acquired popular foot-care brand, Compeed.
You may also be interested in...
France's HRA is looking to tap into consumer demand for foot care products in the Middle East by rolling out its Compeed brand in select markets across the region.
New OTC medicines for fungal nail infections and verrucas have been launched in the UK by Galderma, Reckitt Benckiser and Vemedia, while new foot-care products have also been introduced by Blistex, Epitact and Dermatonics.
EllaOne and Compeed manufacturer HRA Pharma is set to establish a notable presence in the US consumer health market by acquiring the Mederma dermatology range from Germany's Merz.